Prognose

Für dieses Unternehmen liegen uns keine Analysten-Daten vor.

Scoring-Modelle

Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.

Beliebteste Broker

News

13.07. - 12:00 Uhr

CannaPharmaRX, Inc. Closes Sale of Hanover Facility for $2,000,000 CAD

CALGARY, AB / ACCESSWIRE / July 13, 2021 / CannapharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities in Canada, announced today the sale of its Hanover, Ontario facility for $2,000,000 CAD. The Hanover facility includes ten acres of land and 48,800 square feet of growing space. » Mehr auf accesswire.com
24.06. - 12:30 Uhr

CannaPharmaRx Comments on Stock Promotion Flag

CALGARY, AB / ACCESSWIRE / June 24, 2021 / CannaPharmaRx, Inc. (OTC PINK:CPMD) a future leader in ultramodern, highly efficient cannabis production facilities in Canada, announced that it has been brought to its attention that a Third Party has issued a Press Release. Management believes this update is from an unaffiliated third party posting information about the company. » Mehr auf accesswire.com
16.06. - 12:30 Uhr

CannaPharmaRX, Inc. Signs Agreement with Israeli Group K&K Consulting

Agreement Provides Exposure to Israeli Medicinal Cannabis Market CALGARY, AB / ACCESSWIRE / June 16, 2021 / CannapharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities in Canada, announced today it has formally executed an agreement with K&K Consulting to broaden its exposure to the medical cannabis market in Israel. Based upon current analyses, the cannabis patient numbers in Israel have reached a record high in 2020, with over 60,000 users. » Mehr auf accesswire.com

Unternehmenszahlen

Im letzten Quartal hatte CANNAPHARMARX A DL-,0001 einen Umsatz von 0,00 € und ein Nettoeinkommen von 2,08 Mio €

(EUR)	Sep. 2022	YOY
Umsatz	0,00	-
Bruttoeinkommen	3,10k	-
Nettoeinkommen	2,08 Mio	-
EBITDA	522,71k	-

Fundamentaldaten

Metrik	Wert
Marktkapitalisierung	2,05 Mio €
Anzahl Aktien	257,57 Mio
52 Wochen-Hoch/Tief	0,0243 € - 0,00467 €
Dividenden	Nein
Beta	0,25
KGV (PE Ratio)	0,26
KGWV (PEG Ratio)	0,0035
KBV (PB Ratio)	0,14
KUV (PS Ratio)	0,00

Unternehmensprofil

CannaPharmaRX, Inc. ist in der Cannabisbranche in Kanada tätig. Das Unternehmen verhandelt, erwirbt und entwickelt verschiedene Cannabisanbauprojekte. Das Unternehmen wurde 1998 gegründet und hat seinen Sitz in Calgary, Kanada.